Yang Kai-Chien, Kyle John W, Makielski Jonathan C, Dudley Samuel C
From the Department of Pharmacology (K.-C.Y.) and Division of Cardiology, Department of Internal Medicine (K.-C.Y.), National Taiwan University Hospital, Taipei, Taiwan; Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin, Madison (J.W.K., J.C.M.); and Lifespan Cardiovascular Institute, the Providence VA Medical Center, and Brown University, RI (S.C.D.).
Circ Res. 2015 Jun 5;116(12):1937-55. doi: 10.1161/CIRCRESAHA.116.304691.
Ventricular arrhythmia is the leading cause of sudden cardiac death (SCD). Deranged cardiac metabolism and abnormal redox state during cardiac diseases foment arrhythmogenic substrates through direct or indirect modulation of cardiac ion channel/transporter function. This review presents current evidence on the mechanisms linking metabolic derangement and excessive oxidative stress to ion channel/transporter dysfunction that predisposes to ventricular arrhythmias and SCD. Because conventional antiarrhythmic agents aiming at ion channels have proven challenging to use, targeting arrhythmogenic metabolic changes and redox imbalance may provide novel therapeutics to treat or prevent life-threatening arrhythmias and SCD.
室性心律失常是心源性猝死(SCD)的主要原因。心脏疾病期间心脏代谢紊乱和氧化还原状态异常,通过直接或间接调节心脏离子通道/转运体功能,促发心律失常底物。本综述介绍了目前关于代谢紊乱和过度氧化应激与离子通道/转运体功能障碍之间联系的证据,这些功能障碍易引发室性心律失常和SCD。由于旨在作用于离子通道的传统抗心律失常药物已证明使用起来具有挑战性,针对致心律失常的代谢变化和氧化还原失衡可能会提供新的治疗方法来治疗或预防危及生命的心律失常和SCD。